Form 6-K AKUMIN INC. For: May 13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the Month of May 2021

001-39479

(Commission File Number)

Akumin Inc.

(Exact name of Registrant as specified in its charter)

8300 W. Sunrise Boulevard

Plantation, Florida 33322

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☐             Form 40-F  ☒

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Exhibit Index

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Exhibit 99.1

Akumin Reports the Results of its Annual General and Special Meeting

May 13, 2021 – Plantation, FL – Akumin Inc. (“Akumin” or the “Corporation”) (NASDAQ/TSX: AKU) held its annual general and special meeting of shareholders (the “Meeting”) today, May 13, 2021, on a virtual meeting platform. A total 47,315,152 shares, representing approximately 67.421% of shares outstanding, were represented at the meeting or by proxy at the meeting.

Further to TSX reporting requirements, the voting in relation to the election of directors was conducted at the Meeting and the results were as follows:

The appointment of the auditors, as described in the Corporation’s management information circular dated April 7, 2021 (the “Circular”), was duly approved by the requisite number of votes. The shareholders also passed a resolution to confirm an amendment to the Corporation’s general bylaw, previously passed by the board of directors, to increase the quorum requirement for shareholder meetings from 10% of the issued and outstanding shares being represented to 33-1/3% of the issued and outstanding shares being represented at the meeting, as further described in the Circular.

About Akumin

Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of owned and/or operated imaging centers located in Florida, Texas, Pennsylvania, Delaware, Illinois, Kansas and Georgia. By combining our clinical expertise with the latest advances in technology and information systems, our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. Our imaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures.

For further information:

R. Jeffrey White

Investor Relations

1-866-640-5222

[email protected]

Exhibit 99.2

AKUMIN INC.

REPORT OF VOTING RESULTS

In accordance with Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, the following sets out the matters voted upon at the Annual General and Special Meeting of shareholders (the “Meeting”) of Akumin Inc. (the “Company”) held on May 13, 2021. Each of the matters set out below is described in greater detail in the Company’s Management Information Circular (the “Circular”) dated April 7, 2021 mailed to shareholders prior to the Meeting.

Each of the five nominees listed in the Circular was elected as a director of the Company for the ensuing year or until their successor is elected or appointed. The results of the votes cast are set out below:

Ernst & Young LLP was reappointed as the auditor of the Company until the next annual meeting of shareholders, and the Audit Committee of the Company was authorized to fix the remuneration of the auditors. The results of the votes cast are set out below:

The Company’s shareholders approved and confirmed amendments to the Company’s By-law No. 1 which are reflected in Amended and Restated By-Law No. 1, which amendments increase the quorum requirement for meetings of shareholders. The results of the votes cast are set out below:

* * * * *